IL23R and graft versus host disease: Thus, decreasing IL-17 production through the mutant IL-23 receptor leads to a lower likelihood of invasion by Aspergillus, as well as to protection against graft-versus-host disease (GVHD) in stem cell transplant recipients [40,47,48].